The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Bisphosphonates: mechanisms of action.
Open accessAbstract
Because of its failure to act when given orally and its rapid hydrolysis when given parenterally, pyrophosphate was used therapeutically only in scintigraphy and against dental calculus. This prompted us to search for analogs that showed similar physicochemical activity but resisted enzymatic hydrolysis and, therefore, would not be degraded metabolically. The bisphosphonates fulfilled these conditions. This review will deal with the mechanisms of action of these compounds. In vitro results, as well as results both in animals and humans, will be integrated in an attempt to deduce the current state of the art. Various reviews have been published recently on bisphosphonates and may be consulted also for information on other aspects (8 ‐14). Since the literature in this field is plentiful, selective citation was necessary. Priority is given to papers dealing with the mechanisms of action. Since many papers often deal with the same finding, in most cases only the first ones are quoted. Subsequent papers are quoted only if they convey new knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wimalawansa, S. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80102-8 · Cited by 152
RetractedCaspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Natural and synthetic non-peptide antigens recognized by human γδ T cells
Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., & Bloom, B. R. (1995) · Nature · doi:10.1038/375155a0 · Cited by 1,013
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Self-citationRole of osteoblasts in hormonal control of bone resorption—A hypothesis
Rodan, G. A., & Martin, T. J. (1981) · Calcified Tissue International · doi:10.1007/bf02409454 · Cited by 982
Self-citationIntermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Bisphosphonates: A review of their pharmacokinetic properties
Lin, J. H. (1996) · Bone · doi:10.1016/8756-3282(95)00445-9 · Cited by 932
Esophagitis Associated with the Use of Alendronate
de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M. J., Pinkas, H., & Wang, K. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351403 · Cited by 764
Fleisch, H., Graham, R., Russell, G., & Francis, M. D. (1969) · Science · doi:10.1126/science.165.3899.1262 · Cited by 758
Self-citationGarnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Francis, M. D., Graham, R., Russell, G., & Fleisch, H. (1969) · Science · doi:10.1126/science.165.3899.1264 · Cited by 608
Self-citationFleisch, H. (1991) · Drugs · doi:10.2165/00003495-199142060-00003 · Cited by 581
Self-citationPaterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.
Boyce, B. F., Yoneda, T., Lowe, C., Soriano, P., & Mundy, G. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116032 · Cited by 550
The when and how of Src regulation
Cooper, J. A., & Howell, B. (1993) · Cell · doi:10.1016/0092-8674(93)90634-3 · Cited by 533
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Effect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium Homeostasis
FLEISCH, H., RUSSELL, R. G. G., & STRAUMANN, F. (1966) · Nature · doi:10.1038/212901a0 · Cited by 517
Self-citationSchenk, R., Merz, W. A., Mühlbauer, R., Russell, R. G. G., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547219 · Cited by 482
Self-citationBisphosphonates in Bone Disease: From the Laboratory to the Patient
Fleisch, H. A. (1995) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 472
Self-citationMechanisms of calcification: role of collagen, polyphosphates, and phosphatase
Fleish, H., & Neuman, W. F. (1961) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1961.200.6.1296 · Cited by 444
Frith, J. C., Mönkkönen, J., Blackburn, G. M., Russell, R. G. G., & Rogers, M. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1358 · Cited by 437
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki, A., Boyce, B. F., Story, B. M., Wright, K. R., Chapman, M., Boyce, R. W., Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 417
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
Green, J. R., Müller, K., & Jaeggi, K. A. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090521 · Cited by 415
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni, M., Guenther, H. L., Fleisch, H., Collin, P., & Martin, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116422 · Cited by 412
Self-citationThe bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
Seedor, J. G., Quartuccio, H. A., & Thompson, D. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060405 · Cited by 407
The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates
Francis, M. D. (1969) · Calcified Tissue Research · doi:10.1007/bf02058658 · Cited by 399
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity
Shipman, C. M., Rogers, M. J., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2713086.x · Cited by 398
Balena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., & Frankenfield, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116872 · Cited by 396
The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
Jung, A., Bisaz, S., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547227 · Cited by 381
Self-citationThe acute-phase response after bisphosphonate administration
Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Lo Cascio, V. (1987) · Calcified Tissue International · doi:10.1007/bf02556671 · Cited by 357
Hughes, D. E., MacDonald, B. R., Russell, R. G., & Gowen, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114100 · Cited by 357
Harris, S. T., Watts, N. B., Jackson, R. D., Genant, H. K., Wasnich, R. D., Ross, P., Miller, P. D., Licata, A. A., & Chesnut, C. H. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90350-x · Cited by 354
Isolation from urine of pyrophosphate, a calcification inhibitor
Fleisch, H., & Bisaz, S. (1962) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1962.203.4.671 · Cited by 349
Self-citationTwo modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Boissier, S., Magnetto, S., Frappart, L., Cuzin, B., Ebetino, F. H., Delmas, P. D., & Clézardin, P. (1997) · PubMed · Cited by 343
Russell, R. G. G., Mühlbauer, R. C., Bisaz, S., Williams, D. A., & Fleisch, H. (1970) · Calcified Tissue Research · doi:10.1007/bf02196199 · Cited by 341
Self-citationReid, I. R., Alexander, C. J., King, A. R., & Ibbertson, H. K. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92721-3 · Cited by 341
Parfitt, A. M., Mundy, G. R., Roodman, G. D., Hughes, D. E., & Boyce, B. F. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110203 · Cited by 336
Fleisch, H. A., Russell, R. G. G., Bisaz, S., Mühlbauer, R. C., & Williams, D. A. (1970) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1970.tb00591.x · Cited by 325
Self-citationSchenk, R., Eggli, P., Fleisch, H., & Rosini, S. (1986) · Calcified Tissue International · doi:10.1007/bf02555748 · Cited by 315
Self-citationCarano, A., Teitelbaum, S. L., Konsek, J. D., Schlesinger, P. H., & Blair, H. C. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114459 · Cited by 314
McSHEEHY, P. M. J., & CHAMBERS, T. J. (1986) · Endocrinology · doi:10.1210/endo-119-4-1654 · Cited by 310
Structure-activity relationships of various bisphosphonates
Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R., & Hagan, P. (1983) · Calcified Tissue International · doi:10.1007/bf02405012 · Cited by 306
Self-citationBisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
Vitte, C. (1996) · Endocrinology · doi:10.1210/en.137.6.2324 · Cited by 299
Meunier, P. J., & Boivin, G. (1997) · Bone · doi:10.1016/s8756-3282(97)00170-1 · Cited by 298
Amin, D., Cornell, S., Gustafson, S., Needle, S., Ullrich, J., Bilder, G., & Perrone, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41388-4 · Cited by 281
Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264
Studies of the oral bioavailability of alendronate*
Gertz, B. J., Holland, S. D., Kline, W. F., Matuszewski, B. K., Freeman, A., Quan, H., Lasseter, K. C., Mucklow, J. C., & Porras, A. G. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90245-7 · Cited by 262
Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones
Masarachia, P., Weinreb, M., Balena, R., & Rodan, G. A. (1996) · Bone · doi:10.1016/8756-3282(96)00182-2 · Cited by 248
Self-citationYoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
STUDIES ON X RAY ABSORPTION AND DIFFRACTION OF BONE TISSUE
Amprino, R., & Engström, A. (1952) · Cells Tissues Organs · doi:10.1159/000140734 · Cited by 244
Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro
Robertson, W. G., Peacock, M., & Nordin, B. E. C. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90114-9 · Cited by 240
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Mühlbauer, R. C., Bauss, F., Schenk, R., Janner, M., Bosies, E., Strein, K., & Fleisch, H. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060915 · Cited by 239
Self-citationNussbaum, S. R., Younger, J., Vandepol, C. J., Gagel, R. F., Zubler, M. A., Chapman, R., Henderson, I. C., & Mallette, L. E. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90282-t · Cited by 228
Eggelmeijer, F., Papapoulos, S. E., van Paassen, H. C., Dijkmans, B. A. C., Valkema, R., Westedt, M. L., Landman, J., Pauwels, E. K. J., & Breedveld, F. C. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390307 · Cited by 227
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
Tucci, J. R., Tonino, R. P., Emkey, R. D., Peverly, C. A., Kher, U., & Santora, A. C. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00282-3 · Cited by 220
Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., & Suda, T. (1995) · Bone · doi:10.1016/s8756-3282(95)00150-6 · Cited by 218
Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., & Delmas, P. D. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100418 · Cited by 216
Inhibition of Wear Debris Mediated Osteolysis in a Canine Total Hip Arthroplasty Model
Shanbhag, A. S., Hasselman, C. T., & Rubash, H. E. (1997) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199711000-00005 · Cited by 216
Pennanen, N., Lapinjoki, S., Urtti, A., & Mönkkönen, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016281608773 · Cited by 211
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., & Holmström, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92755-1 · Cited by 209
Thiébaud, D., Sauty, A., Burckhardt, P., Leuenberger, P., Sitzler, L., Green, J. R., Kandra, A., Zieschang, J., & Palacios, P. I. D. (1997) · Calcified Tissue International · doi:10.1007/s002239900353 · Cited by 206
DIPHOSPHONATES AND PAGET'S DISEASE OF BONE
SMITH (1971) · The Lancet · doi:10.1016/s0140-6736(71)91447-4 · Cited by 203
van Holten-Verzantvoort, A. T., Bijvoet, O. L. M., Hermans, J., Harinck, H. I. J., Elte, J. W. F., Beex, L. V. A. M., Cleton, F. J., Kroon, H. M., Vermey, P., Neijt, J. P., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92555-4 · Cited by 202
The Influence of Two Diphosphonates on Calcium Metabolism in the Rat
Gasser, A. B., Morgan, D. B., Fleisch, H. A., & Richelle, L. J. (1972) · Clinical Science · doi:10.1042/cs0430031 · Cited by 202
Self-citationFOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE
Boyce, B. F., Fogelman, I., Ralston, S., Smith, L., Johnston, E., & Boyle, I. T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92272-4 · Cited by 196
Flanagan, A. M., & Chambers, T. J. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90021-4 · Cited by 195
Dr. Rogers, M. J., Chilton, K. M., Coxon, F. P., Lawry, J., Smith, M. O., Suri, S., & Russel, R. G. G. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111015 · Cited by 194
Schmidt, A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., Wesolowski, G., Leu, C. T., Huang, Z., Ramachandaran, C., Rodan, S. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3068 · Cited by 194
Self-citationRENAL FAILURE ASSOCIATED WITH INTRAVENOUS DIPHOSPHONATES
Bounameaux, H., Schifferli, J., Montani, J.-P., Jung, A., & Chatelanat, F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91465-4 · Cited by 193
Dr. Löwik, C. W. G. M., Van Der Pluijm, G., Van Der Wee-Pals, L. J. A., Van Treslong-De Groot, H. B., & Bijvoet, O. L. M. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030210 · Cited by 191
Fleisch, H., Russell, R. G. G., Bisaz, S., Casey, P. A., & Mühlbauer, R. C. (1968) · Calcified Tissue Research · doi:10.1007/bf02065192 · Cited by 190
Self-citationIntermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
WATTS, N. B., HARRIS, S. T., GENANT, H. K., WASNICH, E. D., MILLER, P. D., JACKSON, R. D., LICATA, A. A., ROSS, P., WOODSON, G. G., YANOVER, M. J., et al. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199101000-00023 · Cited by 190
Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women1
Bone, H. G., Downs, R. W., Tucci, J. R., Harris, S. T., Weinstein, R. S., Licata, A. A., McClung, M. R., Kimmel, D. B., Gertz, B. J., Hale, E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3682 · Cited by 189
Fitton, A., & McTavish, D. (1991) · Drugs · doi:10.2165/00003495-199141020-00009 · Cited by 187
Harinck, H. I., Papapoulos, S. E., Blanksma, H. J., Moolenaar, A. J., Vermeij, P., & Bijvoet, O. L. (1987) · BMJ · doi:10.1136/bmj.295.6609.1301 · Cited by 183
DIPHOSPHONATES IN THE TREATMENT OF MYOSITIS OSSIFICANS
Bassett, C. A. L., Donath, A., Macagno, F., Preisig, R., Fleisch, H. A., & Francis, M. D. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92293-4 · Cited by 182
Self-citationParathyroid hormone-related protein and bone metastases
Guise, T. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.0.co;2-m · Cited by 180
PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATE
REGINSTER, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92927-9 · Cited by 178
Sauty, A., Pecherstorfer, M., Zimmer-Roth, I., Fioroni, P., Juillerat, L., Markert, M., Ludwig, H., Leuenberger, P., Burckhardt, P., & Thiébaudi, D. (1996) · Bone · doi:10.1016/8756-3282(95)00448-3 · Cited by 176
Pamidronate: An unrecognized problem in gastrointestinal tolerability
Lufkin, E. G., Argueta, R., Whitaker, M. D., Cameron, A. L., Wong, V. H., Egan, K. S., O'Fallon, W. M., & Riggs, B. L. (1994) · Osteoporosis International · doi:10.1007/bf01622190 · Cited by 172
Delmas, P. D., Vergnaud, P., Arlot, M. E., Pastoureau, P., Meunier, P. J., & Nilssen, M. H. L. (1995) · Bone · doi:10.1016/8756-3282(95)00113-r · Cited by 171
Zhang, D., Udagawa, N., Nakamura, I., Murakami, H., Saito, S., Yamasaki, K., Shibasaki, Y., Morii, N., Narumiya, S., Takahashi, N., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2285 · Cited by 169
WRONSKI, T. J., DANN, L. M., SCOTT, K. S., & CROOKE, L. R. (1989) · Endocrinology · doi:10.1210/endo-125-2-810 · Cited by 166
Adachi, H., Igarashi, K., Mitani, H., & Shinoda, H. (1994) · Journal of Dental Research · doi:10.1177/00220345940730081301 · Cited by 163
Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., & Nagata, N. (1996) · Bone · doi:10.1016/8756-3282(95)00426-2 · Cited by 161
Reitsma, P. H., Bijvoet, O. L. M., Verlinden-Ooms, H., & van der Wee-Pals, L. J. A. (1980) · Calcified Tissue International · doi:10.1007/bf02408534 · Cited by 161
Storm, T., Steiniche, T., Thamsborg, G., & Melsen, F. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080211 · Cited by 160
Effect of Disodium Ethane-l-Hydroxy-1, 1 - Diphosphonate on Bone Formation
King, W. R., Francis, M. D., & Michael, W. R. (1971) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197107000-00021 · Cited by 158
Azuma, Y., Sato, H., Oue, Y., OKABE, K., Ohta, T., Tsuchimoto, M., & Kiyoki, M. (1995) · Bone · doi:10.1016/8756-3282(94)00035-x · Cited by 157
Grip strength and bone mineral density in older women
Kritz‐Silverstein, D. C., & Barrett-Connor, E. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090107 · Cited by 152
Alendronate Treatment of Naturally‐Occurring Periodontitis in Beagle Dogs
Reddy, M. S., Weatherford, T. W., Smith, C. R., West, B., Jeffcoat, M. K., & Jacks, T. M. (1995) · Journal of Periodontology · doi:10.1902/jop.1995.66.3.211 · Cited by 151
Ravn, P., Clemmesen, B., Riis, B. J., & Christiansen, C. (1996) · Bone · doi:10.1016/s8756-3282(96)00229-3 · Cited by 151
The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture
Fast, D. K., Felix, R., Dowse, C. M., Neuman, W. F., & Fleisch, H. A. (1978) · Biochemical Journal · doi:10.1042/bj1720097 · Cited by 150
Self-citationInhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release Diphosphonate
Levy, R. J., Wolfrum, J. M., Schöen, F. J., Hawley, M., Lund, S. A., & Langer, R. (1985) · Science · doi:10.1126/science.3919445 · Cited by 145
Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages
Cecchini, M. G., Felix, R., Fleisch, H. A., & Cooper, P. H. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020209 · Cited by 144
Self-citationContinuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis
Reid, I. R., Wattie, D. J., Evans, M. C., Gamble, G. D., Stapleton, J. P., & Cornish, J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989461 · Cited by 140
Antiresorptive dose-response relationships across three generations of bisphosphonates.
Sietsema, W. K., Ebetino, F. H., Salvagno, A. M., & Bevan, J. A. (1989) · PubMed · Cited by 139
Novel Salvage Pathway Utilizing Farnesol and Geranylgeraniol for Protein Isoprenylation
Crick, D. C., Andres, D., & Waechter, C. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7145 · Cited by 139
Structural requirements for bisphosphonate actions in vitro
van Beek, E. R., Hoekstra, M., Ruit, M. V. D., Löwik, C. W. G. M., & Papapoulos, S. E. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091206 · Cited by 136
Apd in paget's disease of bone role of the mononuclear phagocyte system?
Bijvoet, O. L. M., Frijlink, W. B., Jie, K., van der Linden, H. C., Meijer, C. J. L. M., Mulder, H., Paassen, H. C. V., Reitsma, P. H., Velde, J. T., Vries, E. D., et al. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780231018 · Cited by 133
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
Ralston, S. H., Thiébaud, D., Herrmann, Z., Steinhauer, E., Thurlimann, B. J. K., Walls, J., Lichinitser, M., Rizzoll, R., Hagberg, H., Huss, H., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.48 · Cited by 129
Pecherstorfer, M., Herrmann, Z., Body, J., Manegold, C., Degardin, M., Clemens, M., Thurlimann, B. J. K., Tubiana-Hulin, M., Steinhauer, E. U., Eijkeren, M. V., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.268 · Cited by 124
Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats
Toolan, B. C., Shea, M., Myers, E. R., Borchers, R. E., Seedor, J. G., Quartuccio, H. A., Rodan, G. A., & Hayes, W. C. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071207 · Cited by 124
Self-citationThe effects of bisphosphonates on the resorption cycle of isolated osteoclasts
Selander, K. S., Lehenkari, P. P., & V��n�nen, H. K. (1994) · Calcified Tissue International · doi:10.1007/bf00299317 · Cited by 123
Michael, W. R., King, W. R., & Wakim, J. M. (1972) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(72)90007-5 · Cited by 120
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
Jung, A. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90813-0 · Cited by 120
Plosker, G. L., & Goa, K. L. (1994) · Drugs · doi:10.2165/00003495-199447060-00007 · Cited by 119
Yaffe, A., Iztkovich, M., Earon, Y., Alt, I., Lilov, R., & Binderman, I. (1997) · Journal of Periodontology · doi:10.1902/jop.1997.68.9.884 · Cited by 118
Clodronate kinetics and bioavailability
Yakatan, G. J., Poynor, W. J., Talbert, R. L., Floyd, B. F., Slough, C. L., Ampulski, R. S., & Benedict, J. J. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.51 · Cited by 117
Bisphosphonates Are Incorporated into Adenine Nucleotides by Human Aminoacyl-tRNA Synthetase Enzymes
Rogers, M. J., Brown, R. J., Hodkin, V., Blackburn, G. M., Russell, R. G. G., & Watts, D. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1113 · Cited by 115
The effect of two diphosphonates on the resorption of mouse calvariain vitro
Reynolds, J. J., Minkin, C., Morgan, D. B., Spycher, D., & Fleisch, H. A. (1972) · Calcified Tissue International · doi:10.1007/bf02012561 · Cited by 111
Self-citationEffects of a Bisphosphonate on Experimental Periodontitis in Monkeys
Brunsvold, M. A., Chaves, E. S., Kornman, K. S., Aufdemorte, T. B., & Wood, R. (1992) · Journal of Periodontology · doi:10.1902/jop.1992.63.10.825 · Cited by 110
Zimolo, Z., Wesolowski, G. A., & Rodan, G. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118283 · Cited by 110
Self-citationBoyce, R. W., Paddock, C. L., Gleason, J. R., Sletsema, W. K., & Eriksen, E. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100207 · Cited by 106
Inhibition of antigen-presenting cell function by alendronate in vitro
Sansoni, P., Passeri, G., Fagnoni, F. F., Mohagheghpour, N., Snelli, G., Brianti, V., & Engleman, E. G. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101115 · Cited by 105
The treatment of osteoporosis with disodium ethane-1, 1-diphosphonate.
Jowsey, J., Riggs, B. L., Pj, K., Dl, H., & Bordier, P. (1971) · PubMed · Cited by 104
The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons
Thompson, D. D., Seedor, J. G., Quartuccio, H. A., Solomon, H. F., Fioravanti, C., Davidson, J. S., Klein, H. J., Jackson, R., Clair, J. S., Frankenfield, D., et al. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070812 · Cited by 104
Self-citationThe bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase
David, P., Nguyen, H., Barbier, A., & Baron, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111017 · Cited by 102
Rogers, M. J., Ji, X., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., Bayless, A. V., Ebetino, F. H., & Watts, D. J. (1994) · Biochemical Journal · doi:10.1042/bj3030303 · Cited by 102
Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis
Flora, L. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220405 · Cited by 101
Boonekamp, P. M., Löwik, C. W. G. M., van der Wee-Pals, L. J. A., Ml, V. W.-V. L., & Bijvoet, O. L. (1987) · PubMed · Cited by 100
Mühlbauer, R. C., Russell, R. G. G., Williams, D. A., & Fleisch, H. A. (1971) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1971.tb00640.x · Cited by 99
Self-citationGuy, J. A., Shea, M., Peter, C. P., Morrissey, R., & Hayed, W. C. (1993) · Calcified Tissue International · doi:10.1007/bf01320915 · Cited by 97
Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss
Giannini, S., D’Angelo, A., Malvasi, L., et al. (1993) · Bone · doi:10.1016/8756-3282(93)90240-b · Cited by 95
Ueber die Einwirkung des Chloracetyls auf phosphorige Säure
Menschutkin, N. (1865) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.18651330307 · Cited by 95
van Beek, E. R., Löwik, C. W. G. M., Que, I., & Papapoulos, S. E. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111016 · Cited by 94
Cecchini, M. G., & Fleisch, H. A. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051005 · Cited by 94
Self-citationThe effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes
Felix, R., Graham, R., Russell, R. G. G., & Fleisch, H. A. (1976) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(76)90291-6 · Cited by 93
Self-citationEndo, Y., Nakamura, M., Kikuchi, T., Shinoda, H., Takeda, Y., Nitta, Y., & Kumagai, K. (1993) · Calcified Tissue International · doi:10.1007/bf00298728 · Cited by 92
Li, M., Mosekilde, L., Søgaard, C. H., Thomsen, J. S., & Wronski, T. J. (1995) · Bone · doi:10.1016/8756-3282(95)00115-t · Cited by 89
Alendronate induces gastric injury and delays ulcer healing in rodents
Elliott, S. N., McKnight, W., Davies, N. M., et al. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)01040-0 · Cited by 86
Renal secretion of diphosphonates in rats
Tröhler, U., Bonjour, J., & Fleisch, H. A. (1975) · Kidney International · doi:10.1038/ki.1975.70 · Cited by 85
Self-citationEffect of EHDP on fracture healing in dogs
Lenehan, T. M., Balligand, M. H., Nunamaker, D. M., & Wood, F. E. (1985) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100030413 · Cited by 85
Meunier, P. J., Confavreux, E., Tupinon, I., Hardouin, C., Delmas, P. D., & Balena, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4073 · Cited by 85
Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates
Felix, R., & Fleisch, H. A. (1979) · Biochemical Journal · doi:10.1042/bj1830073 · Cited by 84
Self-citationAlendronate Modulates Osteogenesis of Human Osteoblastic Cells In Vitro
Tsuchimoto, M., Azuma, Y., Higuchi, O., Sugimoto, I., Hiraia, N., Kiyoki, M., & Yamamoto, I. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.25 · Cited by 83
Disaggregation of hydroxyapatite crystals
Bisaz, S., Felix, R., Hansen, N. M., & Fleisch, H. A. (1976) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(76)90151-3 · Cited by 81
Self-citationInhibitory effect of a bisphosphonate (risedronate) on experimental periodontities in rats
Shoji, K., Horiuchi, H., & Shinoda, H. (1995) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1995.tb02134.x · Cited by 80
Recker, R. R., & Saville, P. D. (1973) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(73)90219-6 · Cited by 79
Facilitation and suppression of bone metastasis.
Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 79
Boulenc, X., Marti, E., Joyeux, H., Roques, C., Berger, Y., & Fabre, G. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90328-t · Cited by 78
Nonclinical Model for Assessing Gastric Effects of Bisphosphonates
BLANK, M. A., Ems, B. L., Gibson, G. W., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018849415297 · Cited by 77
Retention of etidronate in human, dog, and rat
Kasting, G. B., & Francis, M. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070507 · Cited by 77
The Prevention of Early Postmenopausal Bone Loss by Cyclical Etidronate Therapy
Herd, R. J. M., Balena, R., Middlesex, S., Blake, G. M., Ryan, P. J., & Fogelman, I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00019-3 · Cited by 76
How Does Alendronate Inhibit Protein-tyrosine Phosphatases?
Skorey, K., Ly, H. D., Kelly, J., Hammond, M., Ramachandran, C., Huang, Z., Gresser, M. J., & Wang, Q. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22472 · Cited by 74
Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages
Stevenson, P. H., & Stevenson, J. R. (1986) · Calcified Tissue International · doi:10.1007/bf02556715 · Cited by 74
The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in rats
Francis, M. D., Flora, L., & King, W. R. (1972) · Calcified Tissue International · doi:10.1007/bf02061949 · Cited by 74
Trechsel, U., Stutzer, A., & Fleisch, H. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113257 · Cited by 74
Self-citationRogers, M. J., Watts, D. J., Russell, R. G. G., Ji, X., Xiong, X., Blackburn, G. M., Bayless, A. V., & Ebetino, F. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090710 · Cited by 73
Diphosphonates inhibit bone resorption by macrophages in vitro
Chambers, T. J. (1980) · The Journal of Pathology · doi:10.1002/path.1711320307 · Cited by 72
Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cells
Felix, R., Bettex, J.-D., & Fleisch, H. A. (1981) · Calcified Tissue International · doi:10.1007/bf02409488 · Cited by 72
Self-citationInfluence of a diphosphonate on the cellular aspect of young bone tissue
Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., Slooff, T. J. J. H., & Wijers, M. (1980) · Calcified Tissue International · doi:10.1007/bf02408548 · Cited by 72
Inhibition by diphosphonates of bone resorption induced by the walker tumor of the rat
Jung, A., Bornand, J., Mermillod, B., Edouard, C. M., & Meunier, P. J. (1985) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(85)90276-9 · Cited by 72
Bikle, D. D., Morey, E. R., Doty, S. B., Currier, P. A., Tanner, S. J., & Halloran, B. P. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091115 · Cited by 71
Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice.
Stearns, M. E., & Wang, M. (1996) · PubMed · Cited by 70
TAKEUCHI, M., SAKAMOTO, S., YOSHIDA, M., Tetsushi, A. B. E., & ISOMURA, Y. (1993) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.41.688 · Cited by 70
Francis, M. D., Hovancik, K., & Boyce, R. W. (1989) · PubMed · Cited by 69
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts
Murakami, H., Takahashi, N., Tanaka, S., et al. (1997) · Bone · doi:10.1016/s8756-3282(97)00025-2 · Cited by 69
Rogers, M. J., Xiong, X., Ji, X., Mönkkönen, J., Russell, R. G. G., Williamson, M. P., Ebetino, F. H., & Watts, D. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012157212793 · Cited by 68
Metabolism of halogenated bisphosphonates by the cellular slime mould dictyostelium discoideum
Rogers, M. J., Russell, R. G. G., Blackburn, G. M., Williamson, M. P., & Watts, D. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91574-a · Cited by 68
Effectiveness of Diphosphonates in Preventing ???Osteoporosis??? of Disuse in the Rat
Michael, W. R., Kino, W. R., & Francis, M. D. (1971) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197107000-00022 · Cited by 67
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor
Hiraga, T., Tanaka, S., Yamamoto, M., Nakajima, T., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00428-9 · Cited by 66
Felix, R., Guenther, H. L., & Fleisch, H. A. (1984) · Calcified Tissue International · doi:10.1007/bf02405302 · Cited by 65
Self-citationGuenther, H. L., Guenther, H. E., & Fleisch, H. A. (1981) · Biochemical Journal · doi:10.1042/bj1960293 · Cited by 63
Self-citationDemonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates.
Dunn, C. J., Galinet, L. A., Wu, H., Nugent, R. A., Schlachter, S. T., Staite, N. D., Aspar, D. G., Elliott, G. A., Essani, N. A., & Rohloff, N. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39487-5 · Cited by 62
Martodam, R. R., Thornton, K. S., Sica, D. A., D'Souza, S. M., Flora, L., & Mundy, G. R. (1983) · Calcified Tissue International · doi:10.1007/bf02405086 · Cited by 61
Singer, I. I., Scott, S., Kazazis, D. M., & Huff, J. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5264 · Cited by 59
Human protein tyrosine phosphatase-σ: Alternative splicing and inhibition by bisphosphonates
Endo, N., Rutledge, S. J., Opas, E. E., Vogel, R., Rodan, G. A., & Schmidt, A. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110415 · Cited by 59
Self-citationPelorgeas, S., Martin, J., & Satre, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90342-g · Cited by 59
Kostenuik, P. J., Orr, F. W., Suyama, K. L., & Singh, G. (1993) · PubMed · Cited by 58
Motoie, H., Nakamura, T., O'uchi, N., Nishikawa, H., Kanoh, H., Abe, T., & Kawashima, H. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100612 · Cited by 55
Inhibition of vitamin D metabolism by ethane-1-hydroxy-1, 1-diphosphonate
Baxter, L. A., DeLuca, H. F., Bonjour, J., & Fleisch, H. A. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90077-0 · Cited by 55
Self-citationPollard, M., & Luckert, P. H. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/75.5.949 · Cited by 55
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemia.
Nussbaum, S. R., Warrell, R. P., Rude, R. K., Glusman, J. E., Bilezikian, J. P., Stewart, A. F., Stepanavage, M., Sacco, J. F., Averbuch, S. D., & Gertz, B. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1618 · Cited by 54
Geusens, P., Nijs, J., der Perre, G. V., Audekercke, R. V., Lowet, G., Goovaerts, S., Barbier, A., Lacheretz, F., Remandet, B., Jiang, Y., et al. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070603 · Cited by 54
Reproduction toxicity studies with pamidronate.
Graepel, P., Bentley, P., Fritz, H., Miyamoto, M., & Slater, S. (1992) · PubMed · Cited by 52
de Vries, E., van der Weij, Veen, C. J. P., Paassen, H. C. V., Jager, M. J., Hp, S., Bijvoet, O. L., & Cats, A. (1982) · PubMed · Cited by 52
Sturzenberger, O. P., Swancar, J. R., & Reiter, G. (1971) · Journal of Periodontology · doi:10.1902/jop.1971.42.7.416 · Cited by 51
Risedronate treatment does not increase microdamage in the canine femoral neck
Forwood, M. R., Burr, D. B., Takano, Y., Eastman, D., Smith, P. N., & Schwardt, J. D. (1995) · Bone · doi:10.1016/8756-3282(95)00120-3 · Cited by 50
Reynolds, J. J., Murphy, H., Mühlbauer, R. C., et al. (1973) · Calcified Tissue International · doi:10.1007/bf02013722 · Cited by 50
The progress of the periodontal syndrome in the rice rat
Gotcher, J. E., & Jee, W. S. S. (1981) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1981.tb00995.x · Cited by 49
Effects of two novel bisphosphonates on bone cells in vitro
Evans, C., & Braidman, I. P. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80055-4 · Cited by 48
A One Year Follow‐Up Study of the Distribution of 14C‐Clodronate in Mice and Rats
Mönkkönen, J. (1988) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1988.tb01843.x · Cited by 48
Fleisch, H. A. (1996) · Osteoporosis International · doi:10.1007/bf01623942 · Cited by 45
Self-citationLarsson, Å. (1974) · Calcified Tissue International · doi:10.1007/bf02008217 · Cited by 45
Perry, H. M., Skogen, W. F., Chappel, J. C., Kahn, A., Wilner, G. D., & Teitelbaum, S. L. (1989) · Endocrinology · doi:10.1210/endo-125-4-2075 · Cited by 45
Anticalcification and antiresorption effects of bisacylphosphonates
Gelder, J. M. V., Breuer, E., Ornoy, A., Schlossman, A., Patlas, N., & Golomb, G. (1995) · Bone · doi:10.1016/8756-3282(95)00081-n · Cited by 44
Cal, J. C., & Daley‐Yates, P. T. (1990) · Toxicology · doi:10.1016/0300-483x(90)90088-x · Cited by 44
Cited by
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Self-citationThe Epidemiology of Distal Radius Fractures
Nellans, K. W., Kowalski, E., & Chung, K. C. (2012) · Hand Clinics · doi:10.1016/j.hcl.2012.02.001 · Cited by 898
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890
Metadata
- Authors
- Rodan, G. A., & Fleisch, H. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-15
- Volume
- 97
- Issue
- 12
- Pages
- 2692-2696
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1993232754
- Cited by
- 921
- References
- 246
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.